Abstract 821: A potent CDK7 inhibitor TY-2699a suppresses palbociclib-resistant breast cancer and has the potential for combination with chemotherapy or immunotherapy in solid tumors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Shengli Dong, Apeng Liang, Shaoqing Chen, Zhengfei Guo, Jian Zhu, Huan Wang, Jing-Lan Mu, Yakun Qi, Meihua Li, Kai Wang, Hongqiang Li, Xinlong Yang, Chao Zhou, Zhiyong He, Zhengzhou, Henan Niu, Mingyu Jiang, Xiugui Chen, Jun Li, Yusheng Wu
Institution: TYK Medicines, Inc.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409625883